Literature DB >> 6480148

Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy.

J A Jungerman, K H Yu, C I Zanelli.   

Abstract

Calculation of the radiation dose at the cellular level is given for several radionuclides that appear promising for radioimmunotherapy using the radiation dose distribution from a point source. The radionuclides have half-lives in the 1-3 day range and have electron ranges up to several hundred micrometers. The investigation emphasizes the physical considerations in radionuclide choice for the radiolabeling of monoclonal antibodies or antibody fragments.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480148     DOI: 10.1016/0020-708x(84)90025-5

Source DB:  PubMed          Journal:  Int J Appl Radiat Isot        ISSN: 0020-708X


  3 in total

Review 1.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

2.  Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.

Authors:  M Gerretsen; G W Visser; R H Brakenhoff; M van Walsum; G B Snow; G A van Dongen
Journal:  Cell Biophys       Date:  1994

3.  Immunohistochemical phenotyping of human solid tumors with monoclonal antibodies in devising biotherapeutic strategies.

Authors:  S K Liao; C Meranda; B P Avner; T Romano; S Husseini; B Kimbro; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.